{
      "ptx_code": "PTX110",
      "chem_name": "Spironolactone",
      "casrn": "52-01-7",
      "dtxsid": "DTXSID6034186",
      "smiles": "[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O",
      "inchikey": "LXMSZDCAJNLERA-ZHYRCANASA-N",
      "label": "PTX110 | Spironolactone",
      "drugbank_id": "DB00421",
      "use_class": "Pharmaceutical",
      "tox_class": "Nephrotoxicity; Hepatotoxicity; Cardiotoxicity",
      "chem_name_user": "Spironolactone",
      "mw_g_mol": "416.58",
      "solubility_h2o_mol_liter": "5.58e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.12e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "6.34",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "",
      "pka_base": "",
      "source_pka": "ACD/GALAS",
      "log_kow_liter_liter": "2.78",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "2.08",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "0.57",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "average_mass": "416.58",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "134.5 \u00b0C",
      "source_melting_point": "Jean-Claude Bradley Open Melting Point Dataset",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "1448.10",
      "baseline_dmagna": "662.14",
      "baseline_celegans": "1441.16",
      "baseline_xlaevis": "412.72",
      "baseline_dmelanogaster": "5839.02",
      "baseline_cells": "3.81e-04",
      "baseline_cells_generic_micromole_liter_free_ec10": "2.16e-04",
      "moa_drugbank": "Spironolactone competitively inhibits aldosterone dependant sodium potassium exchange channels in the distal convoluted tubule.[Label] This action leads to increased sodium and water excretion, but more potassium retention.[Label] The increased excretion of water leads to diuretic and also antihypertensive effects.[Label]",
      "protein_binding": ">90%.[Label] Canrenone is as much as 98% protein bound.[A178165]",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            }
      ],
      "targets": [
            "Androgen receptor",
            "Cytochrome P450 11B2, mitochondrial",
            "Cytochrome P450 2C19",
            "Delta-type opioid receptor",
            "Estrogen receptor alpha",
            "Glucocorticoid receptor",
            "Mineralocorticoid receptor",
            "Nuclear receptor subfamily 1 group I member 2",
            "Peroxisome proliferator-activated receptor gamma",
            "Progesterone receptor",
            "Sex hormone-binding globulin"
      ]
}